Biotie Therapies Oyj

Type: Company
Name: Biotie Therapies Oyj (Biotie Therapies Corp)
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Biotie receives final European milestone from Lundbeck on Selincro French launch

Danish CNS drug specialist Lundbeck (LUN: CO) has brought Selincro (nalmefene) on the market in France. Selincro, developed by Finland’s Biotie Therapies (Nasdaq OMX: BTH1V), is indicated for the reduction of alcohol consumption in adult patients with ... [Published Pharma Letter - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

BRIEF-Biotie and Lundbeck bring Selincro onto market in France

Sept 19 (Reuters) - Biotie Therapies Oyj* Says Selincro enters the market in France* Says Biotie today announced that its partner H. LundbeckA/S (Lundbeck) has brought Selincro onto market in France* Says Biotie is eligible for a milestone payment of ... [Published Reuters UK - Sep 19 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

Tozadenant Found to Reduce Parkinson's ‘Off-Time’ in Phase 2 Trial

In a phase 2 trial, researchers reported that tozadenant, an adenosine A2 receptor antagonist, provided Parkinson's patients one hour a day more control than patients who had been given a placebo.Scientists studying the novel properties of adenosine A2 ... [Published Neurology Today - Sep 05 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

BRIEF-Biotie Therapies Oyj: Selincro enters the market in Germany

9:05am BSTAug 29 (Reuters) - Biotie Therapies Oyj : * Biotie: Selincro enters the market in Germany * Says its partner H.Lundbeck A/S (Lundbeck) has brought Selincro on the market in Germany * Says is eligible for a milestone payment of EUR 2 million ... [Published Reuters UK - Aug 29 2014]
First reported Aug 28 2014 - Updated Aug 29 2014 - 2 reports

Biotie: Selincro enters the market in Germany

(Thomson Reuters ONE via COMTEX) --BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 29 August 2014 at 9.00 a.m. Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has brought Selincro on the market in Germany. According to the ... [Published TradingCharts.com - Aug 29 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

BRIEF-Biotie Therapies Oyj : formal transfer of global rights for Tozadenant concluded

7:15am BSTAug 28 (Reuters) - Biotie Therapies Oyj : * Biotie: formal transfer of global rights for Tozadenant to Biotie concluded * Says it is expected that the phase 3 study will be able to start recruitingpatients during H1 2015, as planned. * Source ... [Published Reuters UK - Aug 28 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Change in the number of votes relating to Bioti...

Change in the number of votes relating to Biotie Therapies Corp.'s shares ... [Published MoneyAM - Aug 21 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Change in the number of votes relating to Biotie Therapies Corp.'s shares

at 10.00 a.m.Change in the number of votes relating to Biotie Therapies Corp.'s sharesThe Swiss subsidiary of Biotie Therapies Corp. ("Biotie" or the "Company"), Biotie Therapies AG (previously Synosia Therapeutics Holding AG and Biotie Therapies Holding ... [Published Benzinga.com - Aug 21 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

BIOTIE THERAPIES : New Method For Biomonitoring of Phthalate Metabolites in Human Urine Using ISOLUTE® ENV+ Solid Phase Extraction Columns

To facilitate the high throughput population screening of phthalate metabolites, sample preparation methods need to be simple, sensitive and robust to mitigate matrix suppression and instrument down time common to many dilute and shoot approaches to mass ... [Published 4 Traders - Aug 21 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

Biotie Therapies Selects Bracket's CDR System™ for Phase 2 Trial of Treatment of Parkinson's Disease

COPENHAGEN, Denmark, July 16, 2014 /PRNewswire/ -- Bracket is pleased to announce that Biotie Therapies, a specialized drug development company focusing on products for neurodegenerative and psychiatric disorders, has selected the CDR System for use as ... [Published PR Newswire: Health - Jul 16 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 1 reports

Neurelis Regains Rights to Intranasal Diazepam Program

SAN DIEGO, July 11, 2014 /PRNewswire/ -- Neurelis, Inc. ("Neurelis") today announced an agreement with Biotie Therapies Corp. ("Biotie") to end the option held by Biotie to purchase Neurelis, clearing the way for Neurelis to commence further development ... [Published PR Newswire: Health - Jul 11 2014]
First reported May 19 2014 - Updated May 19 2014 - 1 reports

Research and Markets: Tozadenant by Biotie (Parkinson's Disease) - Forecast and Market Analysis to 2022

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3f224r/tozadenant) has announced the addition of the "Tozadenant (Parkinson's Disease) - Forecast and Market Analysis to 2022" report to their offering. Tozadenant ... [Published Business Wire Health News - May 19 2014]

Quotes

"His extensive knowledge and experience of the pharmaceutical industry makes him a strong addition to the board. His particular career focus on acquisitions and finance should provide valuable insights to support the company's strategy."
UCB CMO Iris Loew-Friedrich said, "We will continue working with Biotie to make tozadenant phase 3 ready and to ensure a smooth transition of the program back to Biotie."

More Content

All (50) | News (16) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (1) | Press Releases (30)
sort by: Date | Relevance
Biotie receives final European milestone from L... [Published Pharma Letter - Sep 19 2014]
BRIEF-Biotie and Lundbeck bring Selincro onto m... [Published Reuters UK - Sep 19 2014]
Biotie: Selincro enters the market in France [Published GlobeNewswire: Acquisitions News - Sep 19 2014]
Biotie: Selincro enters the market in France [Published GlobeNewswire: Acquisitions News - Sep 19 2014]
Tozadenant Found to Reduce Parkinson's ‘Off-Tim... [Published Neurology Today - Sep 05 2014]
BRIEF-Biotie Therapies Oyj: Selincro enters the... [Published Reuters UK - Aug 29 2014]
Biotie: Selincro enters the market in Germany [Published GlobeNewswire: Advertising News - Aug 29 2014]
Biotie: Selincro enters the market in Germany [Published GlobeNewswire: Advertising News - Aug 29 2014]
Biotie: Selincro enters the market in Germany [Published TradingCharts.com - Aug 29 2014]
BRIEF-Biotie Therapies Oyj : formal transfer of... [Published Reuters UK - Aug 28 2014]
Biotie: Formal transfer of global rights for to... [Published GlobeNewswire: Acquisitions News - Aug 28 2014]
Biotie: Formal transfer of global rights for to... [Published Indianapolis Business Journal - Aug 28 2014]
Report Published: "AvidBiotics Corp. - Product ... [Published SBWire - Aug 26 2014]
Change in the number of votes relating to Bioti... [Published MoneyAM - Aug 21 2014]
Change in the number of votes relating to Bioti... [Published GlobeNewswire: Advertising News - Aug 21 2014]
Change in the number of votes relating to Bioti... [Published GlobeNewswire: Advertising News - Aug 21 2014]
Change in the number of votes relating to Bioti... [Published Benzinga.com - Aug 21 2014]
BIOTIE THERAPIES : New Method For Biomonitoring... [Published 4 Traders - Aug 21 2014]
Correction to Stock Exchange Release: Change in... [Published GlobeNewswire: Acquisitions News - Aug 01 2014]
Correction to Biotie Therapies Corp. interim re... [Published GlobeNewswire: Acquisitions News - Aug 01 2014]
Change in the number of votes relating to Bioti... [Published GlobeNewswire: Advertising News - Jul 30 2014]
Biotie updates outlook on tozadenant and SYN120 [Published GlobeNewswire: Advertising News - Jul 30 2014]
Biotie interim report 1 January - 30 June 2014 [Published GlobeNewswire: Advertising News - Jul 30 2014]
Change in the number of votes relating to Bioti... [Published GlobeNewswire: Advertising News - Jul 30 2014]
Clinical study with Biotie's BTT1023 in primary... [Published GlobeNewswire: Advertising News - Jul 24 2014]
Clinical study with Biotie's BTT1023 in primary... [Published GlobeNewswire: Advertising News - Jul 24 2014]
Biotie: Selincro enters the market in Spain [Published GlobeNewswire: Advertising News - Jul 22 2014]
Biotie: Selincro enters the market in Spain [Published GlobeNewswire: Acquisitions News - Jul 22 2014]
Biotie Therapies Selects Bracket's CDR System™ ... [Published PR Newswire: Health - Jul 16 2014]
Neurelis Regains Rights to Intranasal Diazepam ... [Published PR Newswire: Health - Jul 11 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Biotie Therapies Selects Bracket's CDR System™ ... [Published PR Newswire: Health - Jul 16 2014]
COPENHAGEN, Denmark, July 16, 2014 /PRNewswire/ -- Bracket is pleased to announce that Biotie Therapies, a specialized drug development company focusing on products for neurodegenerative and psychiatric disorders, has selected the CDR System for use as ...
Neurelis Regains Rights to Intranasal Diazepam ... [Published PR Newswire: Health - Jul 11 2014]
SAN DIEGO, July 11, 2014 /PRNewswire/ -- Neurelis, Inc. ("Neurelis") today announced an agreement with Biotie Therapies Corp. ("Biotie") to end the option held by Biotie to purchase Neurelis, clearing the way for Neurelis to commence further development ...
Research and Markets: Tozadenant by Biotie (Par... [Published Business Wire Health News - May 19 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3f224r/tozadenant) has announced the addition of the "Tozadenant (Parkinson's Disease) - Forecast and Market Analysis to 2022" report to their offering. Tozadenant ...
1

Press Releases

sort by: Date | Relevance
Biotie: Selincro enters the market in France [Published GlobeNewswire: Acquisitions News - Sep 19 2014]
Biotie: Selincro enters the market in France [Published GlobeNewswire: Acquisitions News - Sep 19 2014]
Biotie: Selincro enters the market in Germany [Published GlobeNewswire: Advertising News - Aug 29 2014]
Biotie: Selincro enters the market in Germany [Published GlobeNewswire: Advertising News - Aug 29 2014]
Biotie: Formal transfer of global rights for to... [Published GlobeNewswire: Acquisitions News - Aug 28 2014]
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.